| Warfarin |
| Starting
treatment Indications Dosing and monitoring Complications Follow-up |
Unexpected bleed at therapeutic levels of INR
Investigate for underlying malignancy (look for gastrointestinal and
genitourinary especially). b
Why?
Soft tissue or wounds are the commonest bleeding sites
|
Expiry date:
May 2003
Levels of Evidence used in grading these guides
With thanks to Drs. David Keeling, John Reynolds, David Sackett, Sharon Straus and Alan Townsend
for use of their anticoagulation guide on which this one is based.
| Author | CM Ball |
| Reviewer | A Gallus |
| CAT Writer | CM Ball |